Polarean Imaging PLC (LON:POLX) has completed the installation of its 9820 Xenon Polariser system at the University of Kansas (KU) Medical Center.
KU is a major research and teaching hospital and the new technology will form the cornerstone of a new hyperpolarised 129Xe imaging research programme, added the company, which has now installed 23 systems.
The latest unit will be used to “evaluate and assess” responses to therapy in lung disease patients, KU’s Dr Mario Castro said in a statement.
Polarean has developed a drug-device combination which uses hyperpolarised 129-Xenon gas MRI.
By inhaling and holding a small amount of the gas for just a few seconds, the patient is able to create a much stronger MRI signal, providing doctors with multiple images of lung structure and function.